China XD refutes fraud allegations

By Nina Ying Sun
Assistant Managing Editor

Published: July 14, 2014 5:44 pm ET
Updated: July 14, 2014 5:46 pm ET

Image By: Nasdaq China XD Plastics Co. Ltd. officials, when the company was first listed on the Nasdaq exchange.

Related to this story

Topics Materials, Materials Suppliers, China

Automotive compounder China XD Plastics Co. Ltd. today fought back against an earlier report which has questioned its financial reports.

On July 10, Bleecker Street Research posted an article on SeekingAlpha.com saying that China XD’s, “numbers don’t add up.” After that report was published, XD’s share price on Nasdaq fell more than 20 percent.

On July 14, XD issued a detailed statement refuting some of the allegations.

Regarding the most data-based allegation Bleecker made on the consistency, or lack of, between XD’s SEC filings and the income numbers that the company reported to China’s State Administration of Industry and Commerce (SAIC), XD claimed Bleecker failed to include all of its subsidiaries in the calculations. In addition, XD said Bleecker’s methodology is flawed as it does not, for example, take into account any eliminations of inter-group transactions.

As well, XD dismisses Bleecker’s questioning of its gross margins being substantially higher (184 percent higher in 2013) than China’s largest compounder Guangzhou Kingfa Science & Technology Co. Ltd. Instead, it compared its margins with another Chinese automotive compounder, publicly listed Shanghai Pret Composites Co. Ltd. and said the numbers are in line.

It added that Kingfa’s lower margins can be attributed to its low-profit trading business and the broad range of compound materials for various end markets.

XD claimed that its New York-based Chief Financial Officer Taylor Zhang, albeit having worked for two Chinese companies that were accused of fraud by SEC, was not employed by either of them when those companies were accused of wrongdoing. XD also said there has not been any suggestion that Zhang was involved in any alleged wrongdoing.

In response to questioning of its increased days sales outstanding (DSO) in 2013, XD said it was resulted from in the Chinese economy and its “proactive marketing strategy to penetrate the East China market.” DSO indicates the time it takes a company to collect revenue after a sale.

XD also said its R&D expenditures, in terms of percentage of sales, are “reasonable and effective,” although Bleecker called it “relatively miniscule” compared to Kingfa’s.

About its fairly frequent change of auditors (three changes in five years), XD said those decisions were based on the company’s growth and are justifiable.

It’s not the first time China XD was under scrutiny on some of these issues. An August 2011 article on SeekingAlpha.com called for attention to the same issues — mismatched numbers between SEC filings and the financials they reported to the Chinese government, much higher margins than competitors’, CFO’s former employer, among other things. Some of the comments suspected the anonymous author, who claimed to be an investor in China, was a short seller. Other comments found Morgan Stanley’s investment in XD to be reassuring.

XD is based in Harbin in Northeast China with three plants there and is building a fourth production base in Sichuan province in Southwest China.


Comments

China XD refutes fraud allegations

By Nina Ying Sun
Assistant Managing Editor

Published: July 14, 2014 5:44 pm ET
Updated: July 14, 2014 5:46 pm ET

Post Your Comments


Back to story


More stories

Image

Hong Kong's TK eyes expansion, may buy Nypro Tool operation

September 19, 2014 2:49 pm ET

Hong Kong-based mold maker and plastics processor TK Group (Holdings) Ltd. said it's reached a tentative agreement to buy a tooling factory in...    More

Image

3-D printing specialist aims at better materials, faster equipment

September 19, 2014 2:07 pm ET

An exception in the crowded field of boutique vendors and agents at this year's AsiaMold show was Changsha-based Hunan Farsoon Hi-tech Co. Ltd.,...    More

Image

Foster building medical polymers plant

September 19, 2014 1:39 pm ET

Foster Delivery Science is investing $8 million in a new plant in Putnam, Conn., for production of medical polymer blends, as well as rods, film or...    More

Image

BP to restart damaged PTA unit in limited capacity by November

September 19, 2014 10:27 am ET

British Petroleum plc may restart its fire-damaged purified terephthalic acid (PTA) feedstock unit in South Carolina in late October or early...    More

Image

Bayer spinning off plastics business

September 18, 2014 8:49 am ET

Bayer AG will spin off its MaterialScience plastics group into a separate, publicly-traded company within the next 12 to 18 months.    More

Market Reports

Plastics Caps & Closures Market Report

The annual recap of top trends and future outlook for the plastics caps & closures market features interviews with industry thought leaders and Bill Wood’s economic forecast of trends in growing end markets. You will also gain insight on trends in caps design, materials, machinery, molds & tooling and reviews of mergers & acquisitions.

Learn more

Shale Gas Market - Analysis of North American Region

This report highlights the impact of shale-based natural gas on the North American plastics market and features an in-depth analysis of production trends in the United States during 2013 and a forecast for 2014 and beyond.

Learn more

Thermoformed Packaging 2014 Market Review & Outlook – North America

This in-depth report analyzes economic and market trends, legislative/regulatory activity impacting supply and demand, business opportunities and threats, materials pricing, manufacturing technology, as well as growth strategies being implemented by thermoformed packaging companies.

Learn more

Upcoming Plastics News Events

January 14, 2015 - January 14, 2015Plastics in Automotive

February 4, 2015 - February 6, 2015Plastics News Executive Forum 2015

More Events